Moraes, Rodrigo, et al. “Prevalence of Neuropsychiatric Adverse Effects in HIV Patients Treated With Dolutegravir”. Internal Medicine, vol. 26, no. 1, Mar. 2019, pp. 14-20, doi:10.24950/rspmi/original/64/1/2019.